Eyam Health is revolutionizing biologics through machine learning and next-generation nucleic acid delivery. Our Gemini platform enables self-amplifying RNA and DNA therapeutics—delivering multi-antigen vaccines, antibody therapies, and gene payloads without LNPs or cold-chain. Coupled with Jennerator, our M/L design engine, Eyam accelerates development across infectious disease, oncology, chronic illness, and animal health. From long-acting antibodies to gene therapy to cancer vaccines, our delivery system unlocks scalable, durable, and low-cost solutions where legacy platforms fail.